Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Virological Methods
|
February 23, 2020
Comparison of two immunoassays for concurrent detection of HCV antigen and antibodies among HIV/HCV co-infected patients in dried serum/plasma spots
Amare Eshetu, Andrea Hauser, Daniel Schmidt, et al.
Biomedicines
|
December 24, 2021
Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy
Felicitas Escher, Ganna Aleshcheva, Heiko Pietsch, et al.
Hepatology, Medicine and Policy
|
October 6, 2018
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
Stine Nielsen, Martyna Gassowski, Benjamin Wenz, et al.
Viruses
|
November 10, 2019
Detection and Characterization of Human Enteroviruses, Human Cosaviruses, and a New Human Parechovirus Type in Healthy Individuals in Osun State, Nigeria, 2016/2017
Folakemi Abiodun Osundare, Oladele Oluyinka Opaleye, Akeem Abiodun Akindele, et al.
World Journal of Gastroenterology
|
January 30, 2018
Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection
Bui Tien Sy, Nghiem Xuan Hoan, Hoang Van Tong, et al.
Virology Journal
|
February 23, 2017
Detection and genome characterization of four novel bat hepadnaviruses and a hepevirus in China
Bo Wang, Xing-Lou Yang, Wen Li, et al.
Plos One
|
May 23, 2017
Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles
Katrin Bachelier, Susanne Biehl, Viktoria Schwarz, et al.
Antiviral Therapy
|
September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
Jerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.
The International Journal on Drug Policy
|
July 14, 2018
Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study
Lineke Derks, Martyna Gassowski, Stine Nielsen, et al.
Journal of Immunological Methods
|
January 21, 2020
Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots
Amare Eshetu, Andrea Hauser, Matthias An der Heiden, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Virological Methods
|
February 23, 2020
Comparison of two immunoassays for concurrent detection of HCV antigen and antibodies among HIV/HCV co-infected patients in dried serum/plasma spots
Amare Eshetu, Andrea Hauser, Daniel Schmidt, et al.
Biomedicines
|
December 24, 2021
Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy
Felicitas Escher, Ganna Aleshcheva, Heiko Pietsch, et al.
Hepatology, Medicine and Policy
|
October 6, 2018
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
Stine Nielsen, Martyna Gassowski, Benjamin Wenz, et al.
Viruses
|
November 10, 2019
Detection and Characterization of Human Enteroviruses, Human Cosaviruses, and a New Human Parechovirus Type in Healthy Individuals in Osun State, Nigeria, 2016/2017
Folakemi Abiodun Osundare, Oladele Oluyinka Opaleye, Akeem Abiodun Akindele, et al.
World Journal of Gastroenterology
|
January 30, 2018
Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection
Bui Tien Sy, Nghiem Xuan Hoan, Hoang Van Tong, et al.
Virology Journal
|
February 23, 2017
Detection and genome characterization of four novel bat hepadnaviruses and a hepevirus in China
Bo Wang, Xing-Lou Yang, Wen Li, et al.
Plos One
|
May 23, 2017
Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles
Katrin Bachelier, Susanne Biehl, Viktoria Schwarz, et al.
Antiviral Therapy
|
September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
Jerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.
The International Journal on Drug Policy
|
July 14, 2018
Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study
Lineke Derks, Martyna Gassowski, Stine Nielsen, et al.
Journal of Immunological Methods
|
January 21, 2020
Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots
Amare Eshetu, Andrea Hauser, Matthias An der Heiden, et al.
Page
of 3